Atlas Trials

A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

Clinical trial NCT06200597 · COMPLETED

Trial details

NCT number
NCT06200597
Sponsor
Almirall, S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Volunteers
Start date
2023-12-05
Primary completion
2025-05-11
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.